Thymosin Alpha 1 plus anti-PD-1 antibody enters clinical evaluation for advanced melanoma in elderly patients
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Abstract
An open-label, single-arm clinical trial investigates Thymosin Alpha 1 (1.6mg SC) combined with anti-PD-1 (Toripalimab 240mg IV) for advanced melanoma in elderly patients.